Retinal Changes After COVID-19 Infection and COVID-19 Vaccination

References

• Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506. doi:10.1016/S0140-6736(20)30183-5
   PubMed Web of Science ®Google Scholar
• Ashkenazy N, Patel NA, Sridhar J, Yannuzzi NA. Hemi- and central retinal vein occlusion associated with COVID-19 infection in young patients without known risk factors. Ophthalmol Retina. 2020;6(6):520–530.
   Google Scholar
• Shiroma HF, Lima LH, Shiroma YB, et al. Retinal vascular occlusion in patients with the Covid-19 virus. Int J Retin Vitr. 2022;8(1):4–9. doi:10.1186/s40942-022-00371-7
   PubMedGoogle Scholar
• Le NX, Betzler BK, Ng S, et al. The Eye of the Storm: COVID-19 Vaccination and the Eye. Ophthalmol Ther. 2022;11(1):81–100. doi:10.1007/s40123-021-00415-5
   PubMed Web of Science ®Google Scholar
• Padhy SK, Dcruz RP, Kelgaonkar A. Paracentral acute middle maculopathy following SARS-CoV-2 infection: the D-dimer hypothesis. BMJ Case Rep. 2021;14(3):1–2. doi:10.1136/bcr-2021-242043
   Google Scholar
• Venkatesh R, Reddy NG, Agrawal S, Pereira A. COVID-19-associated central retinal vein occlusion treated with oral aspirin. BMJ Case Rep. 2021;14(5):1–3. doi:10.1136/bcr-2021-242987
   Google Scholar
• Afonso MG, Marques JH, Monteiro S, Lume M, Abreu AC, Maia S. Acute macular neuroretinopathy following sars-CoV-2 Vaccination. Retin Cases Br Reports. 2022;17(4):438–440.
   Google Scholar
• Castro CS, Ferreira AS, Silva NP, Lume MR, Furtado MJ. Paracentral acute middle maculopathy after COVID-19 disease: multimodal evaluation. Retin Cases Br Reports. 2022;2022:10–97.
   Google Scholar
• Peters MC, Cheng SSH, Sharma A, Moloney TP. Retinal vein occlusion following COVID −19 vaccination. Clin Exp Ophthalmol. 2022;50:459–461. doi:10.1111/ceo.14056
   PubMed Web of Science ®Google Scholar
• Dehghani A, Ghanbari H, Houshang‐Jahromi M, Pourazizi M. Paracentral acute middle maculopathy and COVID-19 vaccination: causation versus coincidence finding. clinical Case Reports. 2022;10(3):1–4. doi:10.1002/ccr3.5578
   Web of Science ®Google Scholar
• Endo B, Bahamon S, Martínez-Pulgarín DF. Central retinal vein occlusion after mRNA SARS-CoV-2 vaccination: a case report. Indian J Ophthalmol. 2021;69:2865–2866. doi:10.4103/ijo.IJO_1477_21
   PubMed Web of Science ®Google Scholar
• Taquet M, Husain M, Geddes JR, Luciano S, Harrison PJ. Cerebral venous thrombosis and portal vein thrombosis: a retrospective cohort study of 537,913 COVID-19 cases. E Clin Med. 2021;39:101061. doi:10.1016/j.eclinm.2021.101061
   Google Scholar
• Goyal M, Murthy SI, Annum S. Retinal manifestations in patients following COVID-19 infection: a consecutive case series. Indian J Ophthalmol. 2021;69:5.
   PubMed Web of Science ®Google Scholar
• Pichi F, Aljneibi S, Neri P, Hay S, Dackiw C, Ghazi NG. Association of ocular adverse events with inactivated COVID-19 vaccination in patients in Abu Dhabi. JAMA Ophthalmol. 2021;139(10):1131–1135. doi:10.1001/jamaophthalmol.2021.3477
   PubMed Web of Science ®Google Scholar
• Abdin AD, Gärtner BC, Seitz B. Central retinal artery occlusion following COVID-19 vaccine administration. Am J Ophthalmol Case Reports. 2022;26(July 2021):2021–2023. doi:10.1016/j.ajoc.2022.101430
   Google Scholar
• Ishibashi K, Yatsuka H, Haruta M, Kimoto K, Yoshida S, Kubota T. Branch retinal artery occlusions, paracentral acute middle maculopathy and acute macular neuroretinopathy after COVID-19 vaccinations. Clin Ophthalmol. 2022;16(March):987–992. doi:10.2147/OPTH.S357359
   PubMedGoogle Scholar
• Thakar M, Bhattacharya S. Central retinal artery occlusion after vaccination with whole virion inactivatedSARSCoV- 2 vaccine Covaxin. Indian J Ophthalmol. 2022;70:3716–3718. doi:10.4103/ijo.IJO_1148_22
   PubMed Web of Science ®Google Scholar
• Girbardt C, Busch C, Al-Sheikh M, et al. Retinal vascular events after mRNA and adenoviral-vectored covid-19 vaccines—a case series. Vaccines. 2021;9(11):1349. doi:10.3390/vaccines9111349
   Web of Science ®Google Scholar
• Mohamed S, Chan CKM, Tsang CW, et al. Case Report: retinal vasculitis in two adolescents after COVID-19 vaccination. Ocul Immunol Inflamm;2022. 1–5. doi:10.1080/09273948.2022.2129694
   PubMed Web of Science ®Google Scholar
• Sonawane NJ, Yadav D, Kota AR, Singh HV. Central retinal vein occlusion post-COVID-19 vaccination. Indian J Ophthalmol. 2022;70(1):308. doi:10.4103/ijo.IJO_1757_21
   PubMed Web of Science ®Google Scholar
• Abrignani MG, Murrone A, De Luca L, et al. COVID‐19, vaccines, and thrombotic events: a narrative review. J Clin Med. 2022;11(4):1–25. doi:10.3390/jcm11040948
   Web of Science ®Google Scholar
• Casagrande M, Fitzek A, Püschel K, et al. Detection of SARS-CoV-2 in human retinal biopsies of deceased COVID-19 patients. Ocul Immunol Inflamm. 2020;28(5):721–725. doi:10.1080/09273948.2020.1770301
   PubMed Web of Science ®Google Scholar
• Amin MA, Nahin S, Dola TA, Afrin S, Hawlader MDH. Retinal hemorrhage of late post‐COVID‐19 and post‐vaccine‐related pathogenic mechanisms: a new challenge for ophthalmologist in COVID era. Clin Case Reports. 2022;10(2):1–7. doi:10.1002/ccr3.5471
   Web of Science ®Google Scholar
• Li M, Wang Z, Xie C, Xia X. Free Information in English and Mandarin on the Novel Coronavirus COVID- Advances in mRNA Vaccines. Academic Press; 2020.
   Google Scholar
• Watson OJ, Barnsley G, Toor J, Hogan AB, Winskill P, Ghani AC. Global impact of the first year of COVID-19 vaccination: a mathematical modelling study. Lancet Infect Dis. 2022;22(9):1293–1302. doi:10.1016/S1473-3099(22)00320-6
   PubMed Web of Science ®Google Scholar
• Terpos E, Politou M, Ntanasis-Stathopoulos I, et al. High prevalence of anti-PF4 antibodies following ChAdOx1 nCov-19 (AZD1222) vaccination even in the absence of thrombotic events. Vaccines. 2021;9(7):712. doi:10.3390/vaccines9070712
   Web of Science ®Google Scholar
• Elalamy I, Gerotziafas G, Alamowitch S, et al. SARS-CoV-2 vaccine and thrombosis: an expert consensus on vaccine-induced immune thrombotic thrombocytopenia. Thromb Haemost. 2021;121(8):982–991. doi:10.1055/a-1499-0119
   PubMedGoogle Scholar